In a unilateral declaration by the health secretary, several injections promoted by online influencers will become widely available. The F.D.A. had advised against the move.
Category: Drugs (Pharmaceuticals)
-
Kennedy to Allow Broad Use of Unapproved Peptide Injections
The New York Times – Business: -
Melanoma Vaccine Ushers in New Hope for Cancer Patients
The New York Times – Business:Beyond melanoma, scientists are studying cancer vaccines for glioblastoma, pancreatic cancer and more.
-
Melanoma Vaccine Ushers in New Hope for Cancer Patients
The New York Times – Business:Beyond melanoma, scientists are studying cancer vaccines for glioblastoma, pancreatic cancer and more.
-
Employers Shift Rising Health Care Costs Onto Millions of Workers
The New York Times – Business:New surveys show that increases in premiums and deductibles are forcing people to forgo treatments or doctor’s visits while budgets are strained by higher food and gas prices.
-
It’s Time to Shop Medicare, and This Year, It’s Extra Important
The New York Times – Business:Be sure to read your mail this fall — big changes to prescription drug plans and Medicare Advantage provider networks are coming, and could cost you more.
-
Trump Hasn’t Lowered Drug Prices for These Voters
The New York Times – Business:President Trump has been promoting his efforts to reduce drug prices, but many Americans have not seen relief from rising costs for prescriptions and insurance premiums.
-
Private Medicare Plans Are Raising Costs And Forcing Millions To Find New Insurance
The New York Times – Business:As enrollment for Medicare Advantage begins this month, older Americans are confronting fewer options because insurers are discontinuing coverage in many areas.
-
America Wants to Make More Generic Drugs. India Shows Why That’s Hard.
The New York Times – Business:Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home.
-
A.I. Is ‘Better Informed’ Than Doctors, Kennedy Tells Industry-Backed MAHA Summit
The New York Times – Business:The health secretary, Vice President JD Vance and other top officials addressed a conference sponsored by corporations, including A.I. companies and others with business before the government.
-
Have GLP-1 Drugs Changed How You Travel? Tell Us About It.
The New York Times – Travel:The New York Times wants to know how a GLP-1 medication may have affected how readers plan vacations.
-
Trump Promotes Program to Reduce Medicaid Drug Prices
The New York Times – Business:Ahead of the midterm elections, the president said that all states had opted in to an effort to align Medicaid’s prices for medicines with those in other wealthy countries.
-
Use of GLP-1s Like Ozempic Is Forcing Food Companies to Adapt
The New York Times – Business:People on medications for weight loss are buying less food, shrinking their portion sizes and purchasing smaller clothes. Businesses are trying to adjust.
